Others showed that ANXA1 is upregulated in melanoma [46], hepatocellular carcinoma [47], gastric cancer [48] and lung adenocarcinoma [49], which correlates with poor prognosis. This evidence concerns the gene ANXA1 and hepatocellular carcinoma.